DPZ heads into its Monday earnings release with short sellers retreating rapidly and options traders turning more bullish than they have been all year — an unusual combination that sets up a charged print.
The sharpest shift in positioning is in the short book. Short interest has fallen 16% over the past week to 10.5% of the free float — still elevated in absolute terms, but the direction is unambiguous. The move accelerated mid-week, with roughly 625,000 shares covered between July 9 and July 10 alone. That covering has coincided with a 9.6% rally in the stock, which closed at $329.67 on Thursday. Options positioning reinforces the bullish tilt: the put/call ratio has dropped to 0.98, nearly 1.7 standard deviations below its 20-day average of 1.05 and close to its 52-week low of 0.80. Taken together, the setup is less about bears pressing a position and more about traders leaning into a potential recovery story. The lending market remains relaxed — borrow availability is ample at 276%, with a cost to borrow of just 0.55% — so there is no mechanical squeeze pressure driving the covering. Shorts appear to be making a directional call.
The analytic community is harder to read as bullish. Virtually every firm that has moved on DPZ in recent weeks has cut its price target, not raised it. Morgan Stanley trimmed its target to $370 from $395 just yesterday, while Wells Fargo lowered to $325 from $350 — both keeping neutral ratings but acknowledging that the fundamental outlook has softened. Deutsche Bank and UBS maintained Buy ratings but brought targets down to $385 and $375 respectively, signalling confidence in the story tempered by near-term caution. The consensus mean target of $391.57 still sits roughly 19% above Thursday's close, but the direction of travel has been relentlessly downward for a month. The structural debate is straightforward: bulls point to the franchise model's resilience, market share durability in delivery, and scope for new management to re-energise value messaging; bears flag slowing comparable sales, the execution risk that always accompanies a CEO transition, and commodity cost pressure that squeezes both the company and its franchisees' willingness to invest.
One institutional data point is worth flagging. FMR (Fidelity) was the largest holder as of June 30, with 10.2% of shares, and added more than 1.39 million shares in the most recent period — a meaningful addition by any standard. Soroban Capital entered as a new holder with 7.5% of shares as of March 31. Neither of these flows are fresh, but they signal conviction from concentrated, active managers at levels well below the current price — adding a degree of institutional backstop to the setup. Insider activity has been consistently on the sell side, though in small, likely scheduled volumes from the CTO and other executives, and carries little signal at this juncture.
Monday's print will test whether a genuine inflection in comparable sales — or at minimum a credible roadmap from new management — is enough to justify the aggressive short covering and options repositioning that has already taken the stock up nearly 10% this week.
See the live data behind this article on ORTEX.
Open DPZ on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
